Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany

Eur Respir J. 2022 Nov 10;60(5):2200947. doi: 10.1183/13993003.00947-2022. Print 2022 Nov.

Abstract

The lack of circulation of influenza and RSV during the COVID-19 pandemic did not result in a substantial drop in respective antibody levels in the community over 12 months https://bit.ly/3qXVLId

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Influenza, Human* / epidemiology
  • Pandemics
  • Prospective Studies
  • Respiratory Syncytial Virus Infections* / epidemiology
  • Respiratory Syncytial Virus, Human*
  • Respiratory Syncytial Viruses
  • Respiratory Tract Infections*

Substances

  • Antibodies, Viral

Associated data

  • DRKS/DRKS00022416